ALTRAZEAL

🚨 EWMA 2026 - SCIENTIFIC HIGHLIGHTS

Altrazeal published three clinical studies and presented our RCT on diabetic foot ulcers with Dr. Lawrence Lavery at the European Wound Management Association (EWMA) Conference 2026.

Thank you to everyone who stopped by our booth to learn more about Altrazeal. We look forward to collaborating with you.

DATA RELEASE ( ): Mucocutaneous Separation Closed in 11 Days

Ron Sotomayor, RN, BA, CWOCN, Nicole Leveille, MMS, PA-C, and Norbert Garcia-Henriquez, MD, FACS, FASCRS presented a remarkable case study on the use of Altrazeal for treatment of a mucocutaneous separation (MCS) following ileostomy surgery.

Study Outcomes:
✅ 95% wound are reduction within 24 hours
✅ Complete healing in 11 days
✅ Pain score reduction (8/10 to 2/10)
✅ Fewer dressing changes (2 applications)
✅ Extended pouch wear
✅ Reduced nursing time